Physician

Mark A Gallardo, MD

According to 2025 Medicare claims, Mark Gallardo, MD (NPI: 1336159607) practices dermatology in the Hattiesburg, MS market, with the plurality of this provider's patient population coming from Forrest, MS. This provider's primary affiliated billing organization is HATTIESBURG CLINIC PA (NPI: 1740213446; TIN: 640507572) and primary practice location at 39402-1302. Gallardo is affiliated with the Hattiesburg Clinic ACO (ACO ID: A2880), participating under the MSSP model.

Gallardo's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,753 traditional Medicare patients, billed 31,850 HCPCS/CPT codes, and received $459,839 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 2,243 prescription claims across 854 beneficiaries totaling $1,592,700 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 70 records totaling $1,322. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $631,321 to $1,592,700. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$252K$503K2015 Medicare payment: $371,795 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $388,744 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $379,517 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $395,561 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $501,751 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $436,275 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $492,928 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $503,376 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $501,916 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $459,839 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,62911,389$371,795
20161,64112,329$388,744
20171,61111,657$379,517
20181,79215,131$395,561
20192,18320,854$501,751
20201,79416,672$436,275
20211,86221,208$492,928
20221,86422,406$503,376
20231,84426,230$501,916
20241,75331,850$459,839

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$837K$1.7M2015 Drug cost: $631,321 (USD; Tot_Drug_Cst)2016 Drug cost: $687,214 (USD; Tot_Drug_Cst)2017 Drug cost: $849,018 (USD; Tot_Drug_Cst)2018 Drug cost: $896,240 (USD; Tot_Drug_Cst)2019 Drug cost: $837,849 (USD; Tot_Drug_Cst)2020 Drug cost: $1,111,191 (USD; Tot_Drug_Cst)2021 Drug cost: $1,327,847 (USD; Tot_Drug_Cst)2022 Drug cost: $1,303,810 (USD; Tot_Drug_Cst)2023 Drug cost: $1,673,461 (USD; Tot_Drug_Cst)2024 Drug cost: $1,592,700 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20155821,644$631,321
20166441,884$687,214
20176972,104$849,018
20187662,188$896,240
20198172,204$837,849
20207742,212$1,111,191
20218242,210$1,327,847
20228482,324$1,303,810
20238592,328$1,673,461
20248542,243$1,592,700

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths517600$65
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1,5612,433$56
11102Biopsy of related skin growth, first growth644816$54
17000Destruction of precancer skin growth, 1 growth9521,318$32
17003Destruction of precancer skin growth, 2-14 growths8386,552$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab23644$298,061
Cosentyx Sensoready (2 Pens)Secukinumab27756$199,997
TremfyaGuselkumab13702$178,003
OtezlaApremilast22660$103,507
HumiraAdalimumab14392$99,409

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.70$1,322Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Mark A. Gallardo, MD?

Tedicare shows public-source Medicare data for Mark A. Gallardo, MD (NPI 1336159607), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark A. Gallardo, MD have ACO affiliation data?

Mark A. Gallardo, MD is shown with ACO affiliation data for Hattiesburg Clinic ACO (MSSP, ACO ID A2880).

What billing organization is linked to Mark A. Gallardo, MD?

Mark A. Gallardo, MD is linked to HATTIESBURG CLINIC PA (billing NPI 1740213446) in the available physician profile data.

Does Mark A. Gallardo, MD have Open Payments data?

Mark A. Gallardo, MD has 70 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.